myRAteam

It's completely understandable to feel skeptical about starting a new medication — that's actually a really healthy instinct! Here's what's known about Rinvoq (upadacitinib) for RA:

Rinvoq is a once-daily, extended-release tablet that belongs to a class of drugs called JAK inhibitors. It works by blocking a specific Show Full Answer

It's completely understandable to feel skeptical about starting a new medication — that's actually a really healthy instinct! Here's what's known about Rinvoq (upadacitinib) for RA:

Rinvoq is a once-daily, extended-release tablet that belongs to a class of drugs called JAK inhibitors. It works by blocking a specific signaling protein called JAK1, which plays a role in the inflammation that causes RA symptoms.

It's typically prescribed for people who haven't responded well to, or can't tolerate, methotrexate. It can be taken on its own or alongside methotrexate. A few things worth knowing before starting Rinvoq:

- It did not cause weight gain in RA clinical trials, though "increased weight" is listed as a possible side effect
- It's worth asking your doctor how long it's been on the market and what the latest safety data shows
- Always discuss your full treatment history with your rheumatologist so they can confirm it's the right fit for you

The most important step is having an open, honest conversation with your doctor about any concerns. Asking questions like "why is this the right choice for me right now?" can really help ease that skepticism.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

How Do RA Treatments Slow the Progression of Joint Damage?

How Do JAK Inhibitors Treat Rheumatoid Arthritis?